Ignite Creation Date:
2024-05-06 @ 1:29 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01822275
Status:
TERMINATED
Last Update Posted:
2022-12-29
First Post:
2013-03-22
Brief Title:
Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma WHO Grade IV |
Keywords:
| Name | View |
|---|---|
| GBM | View |